发明公开
EP2390265A3 Insulinotropic peptide derivative wherein its N-terminal amino acid is modified
有权
具有修饰的N-末端氨基酸促胰岛素肽衍生物
- 专利标题： Insulinotropic peptide derivative wherein its N-terminal amino acid is modified
- 专利标题（中）： 具有修饰的N-末端氨基酸促胰岛素肽衍生物
-
申请号： EP11162132.2申请日： 2008-07-16
-
公开(公告)号： EP2390265A3公开(公告)日： 2012-03-21
- 发明人: Song, Dae Hae , Lim, Chang Ki , Kim, Young Hoon , Kwon, Se Chang , Lee, Gwan Sun , Bae, Sung Min , Jung, Sung Youb
- 申请人： Hanmi Holdings Co., Ltd.
- 申请人地址： No. 45, Bangi-dong Songpa-gu Seoul 138-828 KR
- 专利权人： Hanmi Holdings Co., Ltd.
- 当前专利权人： Hanmi Holdings Co., Ltd.
- 当前专利权人地址： No. 45, Bangi-dong Songpa-gu Seoul 138-828 KR
- 代理机构： Goodall, Scott
- 优先权： KR20070071071 20070716; US991155P 20071129
- 主分类号： C07K14/65
- IPC分类号： C07K14/65 ; C07K14/00
摘要：
The present invention relates to an N-terminal amino acid-modified insulinotropic peptide having a high activity, and to a pharmaceutical composition comprising the same. The insulinotropic peptide derivatives according to the present invention exhibit therapeutic effects, which are not observed in native and other insulinotropic peptide analogs. Therefore, the insulinotropic peptide derivatives and the pharmaceutical composition comprising the same according to the present invention can be effectively provided for the treatment of the diseases.
公开/授权文献
信息查询
